Fisher & Paykel Healthcare (NZSE:FPH) Long-Term Debt : NZ$300 Mil (As of Sep. 2023)

View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Long-Term Debt?

Fisher & Paykel Healthcare's Long-Term Debt for the quarter that ended in Sep. 2023 was NZ$300 Mil.

Fisher & Paykel Healthcare's quarterly Long-Term Debt increased from Sep. 2022 (NZ$70 Mil) to Mar. 2023 (NZ$79 Mil) and increased from Mar. 2023 (NZ$79 Mil) to Sep. 2023 (NZ$300 Mil).

Fisher & Paykel Healthcare's annual Long-Term Debt increased from Mar. 2021 (NZ$63 Mil) to Mar. 2022 (NZ$63 Mil) and increased from Mar. 2022 (NZ$63 Mil) to Mar. 2023 (NZ$79 Mil).

Fisher & Paykel Healthcare Long-Term Debt Historical Data

The historical data trend for Fisher & Paykel Healthcare's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Long-Term Debt Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Long-Term Debt

Get a 7-Day Free Trial

69.00

22.00

62.80

63.00

79.10

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Long-Term Debt	Get a 7-Day Free Trial															91.00	63.00	70.00	79.10	299.60

Fisher & Paykel Healthcare (NZSE:FPH) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Fisher & Paykel Healthcare Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.